Article
ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.
Brain : a journal of neurology - 1 Aug 2007
Olsen Rikke K J, Olpin Simon E, Andresen Brage S, Miedzybrodzka Zofia H, Pourfarzam Morteza, Merinero Begoña, Frerman Frank E, Beresford Michael W, Dean John C S, Cornelius Nanna, Andersen Oluf, Oldfors Anders, Holme Elisabeth, Gregersen Niels, Turnbull Douglass M, Morris Andrew A M
Abstract excerpt
Multiple acyl-CoA dehydrogenation deficiency (MADD) is a disorder of fatty acid, amino acid and choline metabolism that can result from defects in two flavoproteins, electron transfer flavoprotein (ETF) or ETF: ubiquinone oxidoreductase (ETF:QO). Some patients respond to pharmacological doses of riboflavin. It is unknown whether these patients have defects in the flavoproteins themselves or defects in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
